# Inhaled Nitric Oxide for Patients With MABSC

> **NCT03208764** · PHASE2 · COMPLETED · sponsor: **Beyond Air Inc.** · enrollment: 9 (actual)

## Conditions studied

- Mycobacterium Abscessus Infection

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT03208764
- **Lead sponsor:** Beyond Air Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-24
- **Primary completion:** 2018-05-01
- **Final completion:** 2019-04-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03208764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03208764, "Inhaled Nitric Oxide for Patients With MABSC". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03208764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*